On October 22nd, 2025, Aging Cell published research co-authored by AFAR Grantee Daniel Promislow, DPhil, on protein catabolites as a possible blood-based biomarkers of aging and other findings from the Dog Aging Project.
AFAR's FAST (Finding Aging biomarkers by Searching existing Trials) Initiative aims to determine which targeted and omics-based biomarker approaches are feasible yet innovative enough to advance the development of biomarkers for clinical trials in aging. Learn more here.
Dr. Promislow is a 1998 Glenn Foundation for Medical Research and AFAR Grants for Junior Faculty recipient and a 2010 Glenn Foundation for Medical Research Breakthroughs in Gerontology (BIG) Award recipient.
For more expert-backed insights on the link between human aging and canine longevity, see our Live Better Longer Webinar on The Dog Aging Project here.
Read “Protein Catabolites as Blood-Based Biomarkers of Aging Physiology: Findings from the Dog Aging Project” here.
